Christopher Payne Buys Shares of Hims & Hers Health, Inc. $HIMS
Key Points
- Christopher Payne bought 10,687 shares of Hims & Hers Health, Inc. ($HIMS).
- $HIMS last traded around $30.17.
Christopher Payne, insider at Hims & Hers Health, Inc. ($HIMS), bought 10,687 shares. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Hims & Hers Health, Inc. ($HIMS) Stock
Hims & Hers Health, Inc. Earnings
Analysts Set New Price Targets
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
